Méndez RE

Language: Spanish
References: 17
Page: 551-558
PDF size: 403.98 Kb.

ABSTRACT

In patients with severe HF survival and quality of life is quite limited. Heart transplantation is the only option available that provides some individual benefit. With just over 3000 heart donors per year, the epidemiological impact on the affected population is trivial. Satisfactory results of transplantation and its limitations are until today, the major search engines for alternatives in replacing myocardial function.

REFERENCES

1. Copeland J, Arabia F, Smith R, Nolan, P. Intracoporeal support: The CardioWest total artificial heart. En: Goldstein DJ, Oz MC, editores. Cardiac assist devices. Armonk: Futura; 2000. p. 341-55.

2. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, et al, CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med.

3. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, Kormos R, et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report-2004. J Heart Lung Transplant. 2004;23: 1027-34.

4. ESC Guidelines for the diagnosis and treatment of acute and cronic heart failure 2008. European Heart Journal. 2008;29:2388-2442.

5. Esmore DS, Kayne D, Slamonsen R, et al: First clinical implant of the ventrAssist left ventricular assist system as destination therapy for end-stage heart failure. J heart lung transplant 24:1150, 2005.

6. Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Circulation. 2009;119:1977-2016.

7. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522- 33.

8. Joseph G. Rogers, MD, Continuos flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. Journal of the American College of Cardiology vol 55, No 17, 2010.

9. Piccione W Jr. Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant. 2000;19:S89-94.

10. Potapov EV, Loforte A, Weng Y, Jurmann M, Pasic M, Drews T, et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008;23:185-94.

11. Rao V, Oz MC, Edwards NM, Naka Y. A new off-pump technique for Thoratec right ventricular assist device insertion. Ann Thorac Surg. 2001;71:1719-20.

12. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-43.

13. Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005; 112 Suppl:I32-6.

14. Spanier T, Oz MC, Levin H, et al: Activation of coagulation and fibrinolystic path-ways in patients with left ventricular assist devices. J Thorac Cardiovasc surg 112:1090, 1996.

15. Stevenson LW, Rose EA. Left ventricular assist devices. Bridges to transplantation, recovery, and destination for whom? Circulation. 2003;108:3059-63.

16. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC,Keck BM, et al. Registry of the International Society for Heart and Lung Transplantation: twentysecond official adult heart transplant report: 2005. J Heart Lung Transplant. 2005;24:945-55.

17. Wang SS, Chou NK, Hsu RB, Ko WJ, Yu HY, Chen YS, et al. Heart Transplantation in the patient under ventricular assist complicated with device-related infection. Transplant Proc. 2004;36:2377-9.